MEI Pharma, Inc.·4

Jul 27, 1:59 PM ET

GOLD DANIEL P PHD 4

4 · MEI Pharma, Inc. · Filed Jul 27, 2020

Insider Transaction Report

Form 4
Period: 2020-07-23
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Exercise/Conversion

    Common Stock

    2020-07-23$1.57/sh+12,000$18,840453,632 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-07-2312,000275,500 total
    Exercise: $1.57Exp: 2025-07-28Common Stock (275,500 underlying)
Footnotes (2)
  • [F1]80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
  • [F2]All of the options are fully vested and currently exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION